Multiple infusions of anti-epidermal growth factor receptor (EGFR) monoclonal antibody (EMD 55 900) in patients with recurrent malignant gliomas
- 30 April 1996
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (4), 636-640
- https://doi.org/10.1016/0959-8049(95)00592-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors.Journal of Clinical Oncology, 1994
- Subsets of Glioblastoma Multiforme Defined by Molecular Genetic AnalysisBrain Pathology, 1993
- Monoclonal antibodies to malignant human gliomasMolecular and Chemical Neuropathology, 1992
- Modulation of T-cell function by gliomasImmunology Today, 1991
- Cellular and tumoural heterogeneity of EGFR gene amplification in human malignant gliomasActa Neurochirurgica, 1990
- Response criteria for phase II studies of supratentorial malignant glioma.Journal of Clinical Oncology, 1990
- Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor β2Journal of Neurosurgery, 1989
- Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.Journal of Clinical Oncology, 1987
- Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptideArchives of Biochemistry and Biophysics, 1987
- Expression of epidermal growth factor receptor and associated glycoprotein on cultured human brain tumor cellsJournal of Cellular Biochemistry, 1986